Format

Send to

Choose Destination
See comment in PubMed Commons below
Fortschr Neurol Psychiatr. 2013 May;81 Suppl 1:S3-8. doi: 10.1055/s-0033-1335240. Epub 2013 May 16.

[Differential diagnosis of and pharmacotherapy for bipolar disorder].

[Article in German]

Author information

1
Academic Psychiatry, Institute of Neuroscience, Newcastle upon Tyne, UK. Heinz.Grunze@newcastle.ac.uk

Abstract

Bipolar disorders constitute a group of frequent, chronic psychiatric illnesses with a most severe impact on the patient's life. The course can be very individual and heterogeneous, the best known and most frequent manifestations include the classical bipolar I and bipolar II disorders. However, in Germany even typical bipolar I disorders are underdiagnosed and, consequently, undertreated. This is true despite the fact that the number of pharmacological treatment options has rapidly increased during recent years, both in the field of anticonvulsants and atypical antipsychotics. This supplies us today with new therapeutic strategies, not only for acute mania, but also for bipolar depression and maintenance treatment, and it is feasible to assume that there will be more options available within the next few years.

PMID:
23681714
DOI:
10.1055/s-0033-1335240
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Georg Thieme Verlag Stuttgart, New York
    Loading ...
    Support Center